The company expects shipments to resume by November, and has halves FY27 supply estimate, while saying patient safety and regulatory filings remain unaffected.
​The company expects shipments to resume by November, and has halves FY27 supply estimate, while saying patient safety and regulatory filings remain unaffected. by Soban News (international And National News)
